180 related articles for article (PubMed ID: 26768610)
1. Increased expression of SOX4 is associated with colorectal cancer progression.
Wang B; Li Y; Tan F; Xiao Z
Tumour Biol; 2016 Jul; 37(7):9131-7. PubMed ID: 26768610
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
4. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
5. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
Liu Y; Zeng S; Jiang X; Lai D; Su Z
Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4.
Mou TY; Zhang RR; Wang YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10751-10760. PubMed ID: 31858542
[TBL] [Abstract][Full Text] [Related]
7. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
8. SOX4/HDAC2 Axis Enhances Cell Survivability and Reduces Apoptosis by Activating AKT/MAPK Signaling in Colorectal Cancer.
S A; Chakraborty A; Patnaik S
Dig Dis Sci; 2024 Mar; 69(3):835-850. PubMed ID: 38240850
[TBL] [Abstract][Full Text] [Related]
9. lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4.
Guan B; Chen F; Wu Z; Wang C; Yang J
Dis Markers; 2022; 2022():2876170. PubMed ID: 36193492
[TBL] [Abstract][Full Text] [Related]
10. MiR-133b regulates the proliferation, colony formation, and invasion of bladder cancer cells via inhibiting SOX4.
Zhong M; Jiang F; Song L; Nie M; Lan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):407-415. PubMed ID: 35545336
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
[TBL] [Abstract][Full Text] [Related]
12. MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.
Wang CY; Hua L; Sun J; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(11):14013-20. PubMed ID: 26823713
[TBL] [Abstract][Full Text] [Related]
13. USP20 regulates the stability of EMT transcription factor SOX4 and influences colorectal cancer metastasis.
Guan Y; Jiang SR; Liu JG; Shi JR; Liu ZB
Pathol Res Pract; 2022 May; 233():153879. PubMed ID: 35405623
[TBL] [Abstract][Full Text] [Related]
14. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
15. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
Li Y; Dong M; Kong F; Zhou J
Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
17. SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA-17.
Pan S; Bao D; Li Y; Liu D; Quan S; Wang R
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22910. PubMed ID: 34927777
[TBL] [Abstract][Full Text] [Related]
18. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.
Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B
Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254
[TBL] [Abstract][Full Text] [Related]
19. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
